| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Departments of Medicine and Environmental Health Sciences, The Johns Hopkins University, Baltimore, Maryland
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
In addition to its functional consequences, this question also has relevance to the vascular supply of lung tumors, because the blood flow that supplies lung tumors can arise from either the pulmonary or systemic circulation. The conventional wisdom is that angiogenesis into lung tumors occurs primarily through the bronchial circulation,7,8 but because of anastomoses between the bronchial and pulmonary circulations, embolization of the bronchial circulation is not effective in killing lung tumors. The pulmonary vasculature can thus function as a maintenance vasculature for lung tumors, but with little capacity for angiogenesis; the systemic vasculature provides the primary source for new vessel growth. Atthough this schema may not always occur in metastatic lung tumors,9 there is general agreement implicating the systemic circulation in the lung as the initiator of the blood supply to primary lung tumors.7-9 How this process would operate in the mouse, however, is unclear, because in this species there is no systemic circulation to the airways or parenchyma.6 Thus for the conventional model of lung tumor vascularization to be applicable in mice, there must be some other source of systemic blood flow that can initiate the angiogenesis. There is little discussion of this problem in the literature, but one potential source of this systemic blood supply to primary tumors is adhesions to the mediastinum or thoracic wall.10
In the present study, we describe a new experimental model in the mouse that completely isolates this angiogenic process from tumor development. In this model a new circulation was generated by obstructing one pulmonary artery. Unlike in other species, this new circulation does not arise from the existing systemic vessels in the extraparenchymal airways. Rather the vessels enter the lung directly via a totally new vasculature penetrating the visceral pleural surface. The model thus mimics the vascular source of many lung tumors and allows independent investigation of those factors that can promote or inhibit angiogenesis.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Male C57BL/6J (n = 30; Jackson Laboratories, Bar Harbor, ME) mice 6 weeks old were used in this study. All animals were sedated with a metofane-soaked sponge in a sealed container and then deeply anesthetized with an intraperitoneal injection of ketamine (135 mg/kg) + acepromazine (1.5 mg/kg). They were intubated and mechanically ventilated with 100% oxygen by a ventilation procedure previously described,11 with a tidal volume of 0.2 ml at a rate of 120 breaths/minute. After topical lidocaine, a left thoracotomy was performed in the third intercostal space. The left main pulmonary artery was identified, a 6-O silk suture was placed around it, and then the vessel was ligated. A ligature was place around the third and fourth ribs, and cyanoacrylate adhesive (Future Glue; Pacer Technologies, Rancho Cucamonga, CA) was applied to the cut surface. The thorax was then sealed by tightening the ligature. The animals were extubated and allowed to recover on a heating pad. A subcutaneous injection of 0.2 ml of lactated Ringer’s solution was given to supplement fluid volume. Animal protocols used in this study were reviewed and approved by the Johns Hopkins Institutions Animal Care and Use Committee and were conducted using national guidelines for the care and protection of animals.
Assessment of Perfusion
Vascular perfusion of the left lung was compared to that in the right lung for 12 weeks after left pulmonary artery ligation. Perfusion in individual animals was measured daily for the first week and then at weekly or longer intervals. The extent of perfusion was quantified using 15-µm fluorescently labeled microspheres (Interactive Medical Technologies, Los Angeles, CA; ips1@imt-ltd.com). To measure blood flow, animals were anesthetized with 1000 mg/kg urethane and 5 mg/kg etomidate injected i.p. and mechanically ventilated after tracheostomy. After a small incision in the neck, a jugular vein was dissected free and directly cannulated with a 31-gauge needle connected to PE-10 tubing and a 1-ml syringe. Forty thousand spheres (0.2 ml) of one color were first injected into the jugular vein at a rate of 40 µl/minute. When this was completed, the thorax was opened from the abdomen by cutting along the ventral attachments of the diaphragm. Approximately 50 µl of a 50 µg/ml solution of epinephrine was dripped into the peritoneal cavity to help maintain cardiac function. One hundred thousand spheres (0.1 ml) of another color were injected into the left ventricle through the apex at a rate of 40 µl/minute. Animals were then sacrificed with 50 µl of a supersaturated KCl solution placed directly on the heart. The left and right lungs were excised, washed in fresh saline, and placed in labeled tubes for analysis of the number of spheres. At designated time points, we assessed the pulmonary and systemic perfusion to the left and right lungs in each of 20 mice in vivo. Lungs were digested with proteases to release the spheres, which were then purified through sucrose gradients. The number of spheres in each lung was assessed by flow cytometry with a calibrated reference sample (Interactive Medical Technologies). Because we did not obtain a reference sample from the aorta during infusion, this method of obtaining the total number of spheres per lung sample only provides fractional distributions, not absolute measurements of blood flow. From the injection into the jugular vein, we obtain the fraction of pulmonary artery flow to each lung. From the injection into the left ventricle, we obtain the fraction of cardiac output perfusing each lung.
Lung Mechanics
Immediately before we injected the microspheres into the jugular vein, the lungs were inflated to a static pressure of 25 cmH2O for 4 seconds and then return to normal ventilation at functional residual capacity (FRC) for 1 minute. To assess whether the pulmonary artery ligation of ~40% of the lung would lead to functional changes in lung mechanics, measurements of respiratory system compliance and resistance were then made, using the inspiratory occlusion method as previously described.11 Briefly, this method involves a 200-millisecond occlusion at the end of inspiration. The peak inspiratory pressure can then be partitioned into resistive and compliant components.
Morphology
In several animals 2–3 months after surgery, we injected
methacrylate casting material retrograde into the descending aorta
according to the following procedure. Mice were sacrificed with i.p.
urethane (2000 mg/kg). The abdomen was opened, and the descending aorta
was cannulated with PE-50 tubing filled with saline. The inferior vena
cava was cut, and the systemic circulation was flushed with 1 ml of
saline. The saline syringe was then exchanged for one with 0.5 ml of
the methacrylate mixture (see Table 1
),
and this was injected manually at a rate sufficient to maintain an
infusion pressure of ~200 mmHg. The mouse lung was then inflated with
0.6 ml formalin, and half an hour later the entire thorax was excised
and placed in 10% formalin.
|
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
shows the fractions of cardiac output
and pulmonary blood flow going to the left and right lungs as a
function of time after surgery. Each point in this figure (and in
Figure 2
) shows the measurement in
individual mice. This figure shows an increase in measurable systemic
blood flow to the left lung that began after day 5. This increased up
to 2 weeks, where it seemed to reach a plateau at ~5–6% of cardiac
output.
|
|
.
There is a slightly decreased compliance and increased resistance in
the first week after ligation. To compare the average compliances and
resistances from mice during the first week after ligation to those
measured in mice longer than 2 weeks after ligation we used an unpaired
t-test. The average compliance (± SEM) during the first
week was 0.023 ± 0.0008 ml/cmH2O, and that
longer than 2 weeks after ligation was 0.028 ± 0.0005
(P = 0.0013). The average resistances (± SEM)
over these same two time periods were 1.31 ± 0.04 and 1.13
± 0.03 (P = 0.021), respectively.
On gross inspection, the left lung often appeared less pink than the
right from day 1 to day 3, but after day 4 the left lung color
approached that of the right lung. There was no evidence of gross
atelectasis or necrosis in the left lung at any time after surgery. In
all mice, we observed angiogenic blood vessels arising from the
thoracic wall and entering the lung through the visceral pleura.
Figures 3–5
show examples from one of
the animals injected with a red cast. Figure 3
shows the open thorax
with the ventral surface of the left lung visible. There was
always extensive new vascularization on the dorsal surface of the left
lung near the third intercostal space. Enlarged intercostal arteries
can be seen in the area near the new vascular attachments between the
lung and chest wall. These arteries that now supply the lung show the
characteristic tortuous course of angiogenic vascularization.
Normal-sized intercostal arteries can be seen lower down the thoracic
wall. Figure 4
shows the same thorax,
with the left lung now partially retracted from the chest wall. The
extensive network of anastomotic vessels between the visceral and
parietal pleuras is now readily apparent. The figure shows an
invagination of the upper part of the lung that is caused by the rigid
cast vessels pulling the lung in as the lung is forcibly pulled away
from the chest wall to illustrate the vessels. Figure 5
shows this same left lung now torn
completely free of the anastomoses, pulled down, and turned over to
show the dense vascularization on the dorsal side and on the chest
wall. In several sham-operated controls with no pulmonary artery
ligation, none of these vascular changes were observed.
|
|
|
Figure 6
shows the pleural surface of a
normal mouse lung and that of the left lung 2 days after surgery in the
region close to the third intercostal space. The normal mouse
subpleural region is highly vascularized, with one or more blood
vessels located at each junction of alveolar wall with the pleura. In
the animal with ligated pulmonary artery, enlarged mesothelial cells,
and subpleural blood vessels can be seen to have migrated outside the
disrupted visceral pleura. The arrow in the figure shows one such
example. There also appears to be some necrotic tissue and inflammatory
cells in the thickened parenchymal regions near the pleural surface.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
We found slightly altered mechanics of the respiratory system during the first week after ligation, with the compliance lower and the resistance higher. Reasons for these temporary changes are not entirely clear. There may be some residual stiffness in the left chest wall resulting from the gluing together of two adjacent ribs that could contribute to decreased respiratory system stiffness. However, this would still not explain the increased respiratory resistance. Vascular engorgement is known to decrease the compliance of the lung,12 but because we have decreased the pulmonary vascular pressure after ligation, this mechanism does not seem to be of importance. Perhaps the absence of blood flow increases airway smooth muscle tone, but we have little evidence to support this speculation. Whatever the reason, when the blood flow increases to a new stable level, the mechanics also returned to normal.
Angiogenesis in tumors is necessary if the tumor is to grow to any substantial mass beyond that which can be supplied by simple diffusion from the existing circulation. In the lung, these new blood vessels to primary tumors normally arise from the bronchial circulation,7,8 which has a prolific capacity for angiogenesis. In the process of this growth, new arterial anastomoses often form between the bronchial and pulmonary circulations. These anastomoses allow the pulmonary circulation to supply nutrient flow to the tumor even if the systemic sources are embolized.8 The vascular supply for metastatic lung tumors is more variable, and there is good radiographic evidence for angiogenesis in the pulmonary circulation that supplies these tumors.9 True angiogenesis in pulmonary blood vessels of developed lungs is rare, and the process that occurs in these secondary tumors may be similar to what occurs after pneumonectomy in mature animals, when one lung enlarges and grows into the space previously occupied by the excised lung.13
In addition to supplying blood flow to tumors, angiogenesis occurs in all tissues when the systemic blood supply is compromised.14 Recent studies have followed the time course of angiogenesis after ligation of the femoral artery in the mouse.15 Blood flow recovery in the ischemic hindlimb showed a time course very similar to what we observed in the lung, with little change occurring in the first week and then reaching a plateau by 21 days. In systemic tissues the ischemia will always lead to both hypoxia and impaired metabolism. The key role of oxygen level in some situations is demonstrated by experimental work on the development of the retinal vasculature.16,17 Generation of new blood vessels in the retina is directly correlated with the level of hypoxia and can be prevented with excess oxygen.16 In the lung, however, ischemia caused by hypoxia is clearly not an issue, because the lung is actually better oxygenated when there is no perfusion by deoxygenated venous blood. To the extent that this systemic angiogenesis to the lung has similarities to that in adult systemic tissues after circulatory obstruction, we suggest that hypoxia is not an important or even an essential trigger.
Although there are a host of growth factors, hormones, and chemokines that regulate angiogenesis,4,5 release of angiopoietin-1 by mesenchymal cells and binding to endothelial cell TIE2 receptors have been implicated in models of angiogenesis.18 If this situation obtained in the lung, however, the angiopoietin-1 signal would have to somehow be transmitted through the pleural fluid to the parietal pleural membrane. Although it may seem somewhat unusual for blood vessels to cross the pleural space, there are several instances of this observed in humans and animals. Weibel used a very similar experimental preparation in rats that also used ligation of the left PA.19 Because the rat has a bronchial circulation that supplies intraparenchymal airways, he did show a substantial expansion of the bronchial circulation to the lung after ligation. However, in some animals he showed, as in our results, a dense vascularization between the dorsal lung and chest wall with tortuous intercostal arteries. In humans, clinical treatment of hemoptysis often involves embolization of the bronchial arteries. The body can compensate for this vascular obstruction with angiogenesis of new systemic vessels. This new vascularization can arise from many different locations,20 and one of these is from intercostal arteries that penetrate the pleural space in a manner very similar to what we have found in mice.
In our experimental model in mice, there was new vascularization to the lung from the region of the chest wall adjacent to the surgical incision in the third intercostal space through which the left pulmonary artery was ligated. Thus surgical wound healing in the thoracic wall seems to play an important role in supplying new blood vessels to the lung through the pleural space. This was confirmed in two additional mice, in which a second surgical incision was made through the seventh left intercostal space after the left pulmonary artery was ligated through the normal incision in the third space. In both of these mice, we observed new vascular plexuses adjacent to both of the thoracic incisions. Surgical trauma per se, however, is not sufficient to generate systemic blood flow to the mouse lung. Sham-operated mice, with no pulmonary artery ligation, do not even demonstrate adhesions to the chest wall, let alone new blood vessels to the lung. In another pair of mice, we also attempted to determine whether pulmonary vascular ischemia in close proximity to the site of thoracotomy was necessary for angiogenesis. That is, might there be an angiogenic factor released by the ischemic lung that is distributed throughout the body. In these mice, a second surgical incision was made in the third right intercostal space, after the left pulmonary artery was ligated through the normal incision in the third left intercostal space. No adhesions or vascularization to the right lung was observed, indicating that the signal to the thoracic wall occurs by direct contact. One interesting experimental intervention would be to tie the left pulmonary artery through a right-sided thoracotomy. Unfortunately, in the mouse this is not a simple procedure, and several mice failed to survive after our attempts at this surgery. Although we always observed vascularization from the chest wall, as noted earlier we occasionally observed new systemic vascularization passing through the thymus. Thus at the present time it is not clear whether surgical trauma in this mouse model is essential for the angiogenesis to successfully generate a new functional systemic vasculature to the lung. Surgical trauma in the thoracic wall is not required for systemic angiogenesis in other mammals.
One question that arises from our work relates to the observation that
an increase in microspheres delivered through systemic arteries was not
seen for at least 5 days. How can the lung survive for so many days if
there is neither pulmonary nor systemic blood flow? There are several
possible explanations for this. The first is that there might be
sufficient retrograde flow from pulsations in the left atrium. Flow
probes placed on the pulmonary veins of larger animals have clearly
shown retrograde flow.21
Another possibility is the
existence of some systemic flow that we fail to measure with the
microsphere method. This could happen for three reasons. If the new
vessels located at the pleural surface are smaller than 15 µm in
diameter, the microspheres might not be able to enter the lung, despite
some plasma and red cells being able to trickle through. In addition,
the sensitivity of our method of microsphere analysis is only accurate
to ~200 spheres. So with the 100,000 we injected, we can only
reliably measure flows as small as 0.2% of cardiac output. Because we
did observe vessels in the lung filled with normal looking red blood
cells, either these vessels were communicating with the left atrium, or
there was some systemic circulation (perhaps through fibrous
attachments) that was too small for us to quantify. Figure 6B
clearly
shows a filled blood vessel on the pleural surface that is larger than
15 µm, but because so little is known about the source of the blood
vessels on the normal mouse lung visceral pleura, we cannot distinguish
between these possibilities. It is worth noting, however, that there
were several animals in which there did appear to be some measurable
systemic blood flow to the right lung (Figure 1)
, so perhaps there is a
very small amount of perfusion sufficient to maintain tissue viability
for days. In contrast to an explanation invoking the lack of
penetration of spheres, there is the other extreme, that there are
early anastomotic connections that are actually too large to trap and
hold even 15-µm spheres. Experimental PA occlusions in larger species
have demonstrated the presence of greatly enlarged septal
capillaries.2
If this had occurred in the mice, then our
measurements might be underestimating the actual flow. At the
present time, we cannot choose from among these possible explanations.
Perhaps further studies using smaller and larger microspheres will
provide further insight.
Related to this issue is the nature of the anatomical connections in the lung to the original pulmonary vasculature. Do the new systemic vessels connect to the old pulmonary arteries as the bronchial blood vessels do in other species,2,19 or are the connections at the capillary or pulmonary venous level? We have not performed a systematic histological study that would enable us to address this question definitively. However, it would make teleological sense for the new circulation to link up in some manner to the original pulmonary vasculature, as has been described for the circulation of primary lung tumors.7,22 Flow from the aorta would clearly have minimal influence on gas exchange, but it would maintain the viability of the pulmonary tissues.
One final note relates to the basic anatomy of the mouse lung. Our experiments with microspheres injected into the left heart confirm the absence of a functional bronchial circulation to the parenchymal airways of the normal mouse. Although we only report a systematic study here in the C57BL/6 mice, we have injected microspheres into several other mouse strains. None of the strains we have examined have a systemic circulation supplying the airways in the parenchyma that can be accurately quantified with microspheres (ie, less than 0.2–0.3% of cardiac output). This finding is in agreement with the observations of Verloop,6 who studied the systemic blood vessels to the lung by using casting material. He was able to show a few bronchial blood vessels at the level of the mainstem bronchi, but he found little evidence for this systemic circulation after the airways entered the parenchyma. The reason for this is likely based on the very small wall thickness of mouse airways. A normal mouse intraparenchymal airway is composed of epithelial cells and a thin smooth muscle layer. Outside this smooth muscle, there is a layer of alveolar capillaries and larger vessels where alveolar walls attach. Apparently these pulmonary blood vessels are sufficient to supply nutrients to the epithelium and smooth muscle without the need for a separate systemic airway circulation. The fact that there is no normal systemic circulation raises questions regarding interpretations of numerous experimental studies using murine models of airways disease, where inflammatory cells lavaged from the lungs are thought to be involved in airway responsiveness.23-25 In the mouse, inflammatory cell adhesion and migration into the intraparenchymal airways must occur through capillaries of the pulmonary circulation. This is in sharp contrast to the transit through capillaries of the systemic bronchial circulation that occurs in humans and all other mammals.
In summary, we suggest that this model may offer insights into the process of angiogenesis in general and, more specifically, in the lung. The mouse has a very different response to pulmonary artery ligation compared to all larger mammals. Whether the growth factors and stimuli inducing new vessel growth are unique in mice or the large airway vessels are resistant to these factors remain to be determined. The mouse thus may provide a unique model of lung angiogenesis that may have important implications for general pathophysiology and, more specifically, for the growth and potential resolution of lung tumors.
|
Footnotes |
|---|
Supported by National Institutes of Health grants NHLBI 10342 and NIEHS 03819.
Accepted for publication March 3, 2000.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
 |
|
 |
|
  A. Sukkar, J. Jenkins, J. Sanchez, and E. M. Wagner Inhibition of CXCR2 attenuates bronchial angiogenesis in the ischemic rat lung J Appl Physiol, May 1, 2008; 104(5): 1470 - 1475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. Alvarez, L. Huang, J. A. King, M. K. ElZarrad, M. C. Yoder, and T. Stevens Lung microvascular endothelium is enriched with progenitor cells that exhibit vasculogenic capacity Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L419 - L430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bhattacharya Lung neovascularization: a tale of two circulations Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L417 - L418. [Full Text] [PDF]
|
|
|
|
|
|
E. M. Wagner, J. Sanchez, J. Y. McClintock, J. Jenkins, and A. Moldobaeva Inflammation and ischemia-induced lung angiogenesis Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L351 - L357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. von Ungern-Sternberg, F. Petak, S. Saudan, M. Pellegrini, T. O. Erb, W. Habre, and Swiss Paediatric Respiratory Research Group Effect of cardiopulmonary bypass and aortic clamping on functional residual capacity and ventilation distribution in children. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1193 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sanchez, A. Moldobaeva, J. McClintock, J. Jenkins, and E. Wagner The role of CXCR2 in systemic neovascularization of the mouse lung J Appl Physiol, August 1, 2007; 103(2): 594 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Fields, J. M. Bishai, W. Mitzner, and E. M. Wagner Effects of pulmonary ischemia on lung morphology Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L254 - L258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Wagers, H. C. Haverkamp, J. H. T. Bates, R. J. Norton, J. A. Thompson-Figueroa, M. J. Sullivan, and C. G. Irvin Intrinsic and antigen-induced airway hyperresponsiveness are the result of diverse physiological mechanisms J Appl Physiol, January 1, 2007; 102(1): 221 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Herve, E. Fadel, P. Herve, and E. Fadel Systemic neovascularization of the lung after pulmonary artery occlusion: "decoding the Da Vinci code" J Appl Physiol, April 1, 2006; 100(4): 1101 - 1102. [Full Text] [PDF]
|
|
|
|
|
|
E. M. Wagner, G. Karagulova, J. Jenkins, J. Bishai, and J. McClintock Changes in lung permeability after chronic pulmonary artery obstruction J Appl Physiol, April 1, 2006; 100(4): 1224 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Wagner, I. Petrache, B. Schofield, and W. Mitzner Pulmonary ischemia induces lung remodeling and angiogenesis J Appl Physiol, February 1, 2006; 100(2): 587 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Fadel, E. Wijtenburg, R. Michel, J.-X. Mazoit, R. Bernatchez, B. Decante, E. Sage, M. Mazmanian, and P. Herve Regression of the Systemic Vasculature to the Lung after Removal of Pulmonary Artery Obstruction Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 345 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Savai, J. C. Wolf, S. Greschus, B. G. Eul, R. T. Schermuly, J. Hanze, R. Voswinckel, A. C. Langheinrich, F. Grimminger, H. Traupe, et al. Analysis of Tumor Vessel Supply in Lewis Lung Carcinoma in Mice by Fluorescent Microsphere Distribution and Imaging with Micro- and Flat-Panel Computed Tomography Am. J. Pathol., October 1, 2005; 167(4): 937 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. McClintock and E. M. Wagner Role of IL-6 in systemic angiogenesis of the lung J Appl Physiol, September 1, 2005; 99(3): 861 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Moldobaeva and E. M. Wagner Difference in proangiogenic potential of systemic and pulmonary endothelium: role of CXCR2 Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1117 - L1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Mitzner and E. M. Wagner Vascular remodeling in the circulations of the lung J Appl Physiol, November 1, 2004; 97(5): 1999 - 2004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Petak, B. Babik, Z. Hantos, D. R. Morel, J.-C. Pache, C. Biton, B. Suki, and W. Habre Impact of microvascular circulation on peripheral lung stability Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L879 - L889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Mechanisms and Limits of Induced Postnatal Lung Growth Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 319 - 343. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Dodd-o, M. L. Hristopoulos, N. Faraday, and D. B. Pearse Effect of ischemia and reperfusion without airway occlusion on vascular barrier function in the in vivo mouse lung J Appl Physiol, November 1, 2003; 95(5): 1971 - 1978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Srisuma, S. S. Biswal, W. A. Mitzner, S. J. Gallagher, K. H. Mai, and E. M. Wagner Identification of Genes Promoting Angiogenesis in Mouse Lung by Transcriptional Profiling Am. J. Respir. Cell Mol. Biol., August 1, 2003; 29(2): 172 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. A. Janssen and J. F. M. Smits Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1545 - R1564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. KEANE, J. A. BELPERIO, M. D. BURDICK, J. P. LYNCH III, M. C. FISHBEIN, and R. M. STRIETER ENA-78 Is an Important Angiogenic Factor in Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., December 15, 2001; 164(12): 2239 - 2242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. T. Bloomgarden European Association for the Study of Diabetes Annual Meeting, 2000: Pathogenesis of type 2 diabetes, vascular disease, and neuropathy Diabetes Care, June 1, 2001; 24(6): 1115 - 1119. [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
